Literature DB >> 18937060

Fluorescence and biological evaluation of the La(III) and Eu(III) complexes with 7-methoxychromone-3-carbaldehyde benzoyl hydrazone Schiff base.

Dong-dong Qin1, Gao-fei Qi, Zheng-yin Yang, Jin-cai Wu, Yong-chun Liu.   

Abstract

A novel Schiff base ligand (L = 7-methoxychromone-3-carbaldehyde benzoyl hydrazone) and its La(III) and Eu(III) complexes have been successfully prepared. The crystal structure of [LaL(2)(NO(3))(3)].H(2)O was characterized by X-ray crystallography. It crystallizes in monoclinic, space group C2/c with crystallographic data: a = 27.7173(17) A, b = 10.0002(6) A, c = 14.7884(9) A, beta = 102.6870(10) degrees and Z = 4. In the structure, the La(III) ion satisfies 12 coordination and three nitrate coordinate as bidentate ligand. The biological experiments show that the ligand and its two complexes can strongly bind to DNA through intercalation mode, and the three compounds also exhibit good antioxidant activities against OH(*) and O(2) (-*). Moreover, it is found that the Eu(III) complex exhibits characteristic fluorescence of europium ion in different organic solvent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18937060     DOI: 10.1007/s10895-008-0427-x

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  16 in total

1.  Distachyasin: A new antioxidant metabolite from the leaves of Carex distachya.

Authors:  Antonio Fiorentino; Brigida D'Abrosca; Severina Pacifico; Rosa Iacovino; Claudio Mastellone; Benedetto Di Blasio; Pietro Monaco
Journal:  Bioorg Med Chem Lett       Date:  2006-09-12       Impact factor: 2.823

Review 2.  DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action.

Authors:  Rahul Palchaudhuri; Paul J Hergenrother
Journal:  Curr Opin Biotechnol       Date:  2007-11-07       Impact factor: 9.740

Review 3.  Clinical development of platinum complexes in cancer therapy: an historical perspective and an update.

Authors:  D Lebwohl; R Canetta
Journal:  Eur J Cancer       Date:  1998-09       Impact factor: 9.162

4.  Regulation of gene expression by small molecules.

Authors:  J M Gottesfeld; L Neely; J W Trauger; E E Baird; P B Dervan
Journal:  Nature       Date:  1997-05-08       Impact factor: 49.962

5.  Structure-activity relationships among DNA-gyrase inhibitors. Synthesis and antimicrobial evaluation of chromones and coumarins related to oxolinic acid.

Authors:  T Högberg; M Vora; S D Drake; L A Mitscher; D T Chu
Journal:  Acta Chem Scand B       Date:  1984

Review 6.  Fluorescence quenching studies with proteins.

Authors:  M R Eftink; C A Ghiron
Journal:  Anal Biochem       Date:  1981-07-01       Impact factor: 3.365

7.  Sequence-specific cleavage of double helical DNA by triple helix formation.

Authors:  H E Moser; P B Dervan
Journal:  Science       Date:  1987-10-30       Impact factor: 47.728

8.  Orally active antioxidative copper(II) aspirinate: synthesis, structure characterization, superoxide scavenging activity, and in vitro and in vivo antioxidative evaluations.

Authors:  T Fujimori; S Yamada; H Yasui; H Sakurai; Y In; T Ishida
Journal:  J Biol Inorg Chem       Date:  2005-10-28       Impact factor: 3.358

9.  Effects of the substitution positions of Br group in intercalative ligand on the DNA-binding behaviors of Ru(II) polypyridyl complexes.

Authors:  Hong Xu; Kang-Cheng Zheng; Li-Jun Lin; Hong Li; Yuan Gao; Liang-Nian Ji
Journal:  J Inorg Biochem       Date:  2004-01       Impact factor: 4.155

10.  Species-differentiable sensing of phosphate-containing anions in neutral aqueous solution based on coordinatively unsaturated lanthanide complex probes.

Authors:  Shun-Hua Li; Wen-Tao Yuan; Chang-Qing Zhu; Jin-Gou Xu
Journal:  Anal Biochem       Date:  2004-08-15       Impact factor: 3.365

View more
  1 in total

1.  (E)-3,4,5-Trimeth-oxy-N'-[(4-oxo-4H-chromen-3-yl)methyl-idene]benzo-hydrazide.

Authors:  Yoshinobu Ishikawa; Kohzoh Watanabe
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-03-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.